White Paper

A guide to implementing direct-to-patient strategies

October 5, 2016

Direct-to-patient methods in clinical trials have gained a lot of popularity lately, but
information about them remains scarce. CSM understands the challenges companies
will face in adopting these methods, as well as the processes necessary for their
implementation. Bob Albanese, senior vice-president of strategic development at CSM,
shares his ideas on this important industry trend.

Download to find out more.